Global Communicable Diseases Therapeutics Market Research Report 2023

Report ID: 1897789 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Communicable Diseases Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 HIV
        1.2.3 Influenza
        1.2.4 TB
        1.2.5 Malaria
        1.2.6 Hepatitis
        1.2.7 HPV
    1.3 Market by Application
        1.3.1 Global Communicable Diseases Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Communicable Diseases Therapeutics Market Perspective (2017-2028)
    2.2 Communicable Diseases Therapeutics Growth Trends by Region
        2.2.1 Communicable Diseases Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Communicable Diseases Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Communicable Diseases Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Communicable Diseases Therapeutics Market Dynamics
        2.3.1 Communicable Diseases Therapeutics Industry Trends
        2.3.2 Communicable Diseases Therapeutics Market Drivers
        2.3.3 Communicable Diseases Therapeutics Market Challenges
        2.3.4 Communicable Diseases Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Communicable Diseases Therapeutics Players by Revenue
        3.1.1 Global Top Communicable Diseases Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Communicable Diseases Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Communicable Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Communicable Diseases Therapeutics Revenue
    3.4 Global Communicable Diseases Therapeutics Market Concentration Ratio
        3.4.1 Global Communicable Diseases Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Communicable Diseases Therapeutics Revenue in 2021
    3.5 Communicable Diseases Therapeutics Key Players Head office and Area Served
    3.6 Key Players Communicable Diseases Therapeutics Product Solution and Service
    3.7 Date of Enter into Communicable Diseases Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Communicable Diseases Therapeutics Breakdown Data by Type
    4.1 Global Communicable Diseases Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Communicable Diseases Therapeutics Forecasted Market Size by Type (2023-2028)
5 Communicable Diseases Therapeutics Breakdown Data by Application
    5.1 Global Communicable Diseases Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Communicable Diseases Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Communicable Diseases Therapeutics Market Size (2017-2028)
    6.2 North America Communicable Diseases Therapeutics Market Size by Country (2017-2022)
    6.3 North America Communicable Diseases Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Communicable Diseases Therapeutics Market Size (2017-2028)
    7.2 Europe Communicable Diseases Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Communicable Diseases Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Communicable Diseases Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Communicable Diseases Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Communicable Diseases Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Communicable Diseases Therapeutics Market Size (2017-2028)
    9.2 Latin America Communicable Diseases Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Communicable Diseases Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Communicable Diseases Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Communicable Diseases Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Communicable Diseases Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Detail
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Communicable Diseases Therapeutics Introduction
        11.1.4 Novartis Revenue in Communicable Diseases Therapeutics Business (2017-2022)
        11.1.5 Novartis Recent Development
    11.2 Gilead
        11.2.1 Gilead Company Detail
        11.2.2 Gilead Business Overview
        11.2.3 Gilead Communicable Diseases Therapeutics Introduction
        11.2.4 Gilead Revenue in Communicable Diseases Therapeutics Business (2017-2022)
        11.2.5 Gilead Recent Development
    11.3 GSK
        11.3.1 GSK Company Detail
        11.3.2 GSK Business Overview
        11.3.3 GSK Communicable Diseases Therapeutics Introduction
        11.3.4 GSK Revenue in Communicable Diseases Therapeutics Business (2017-2022)
        11.3.5 GSK Recent Development
    11.4 Janssen Pharmaceutical
        11.4.1 Janssen Pharmaceutical Company Detail
        11.4.2 Janssen Pharmaceutical Business Overview
        11.4.3 Janssen Pharmaceutical Communicable Diseases Therapeutics Introduction
        11.4.4 Janssen Pharmaceutical Revenue in Communicable Diseases Therapeutics Business (2017-2022)
        11.4.5 Janssen Pharmaceutical Recent Development
    11.5 Roche
        11.5.1 Roche Company Detail
        11.5.2 Roche Business Overview
        11.5.3 Roche Communicable Diseases Therapeutics Introduction
        11.5.4 Roche Revenue in Communicable Diseases Therapeutics Business (2017-2022)
        11.5.5 Roche Recent Development
    11.6 BioCryst Pharmaceuticals
        11.6.1 BioCryst Pharmaceuticals Company Detail
        11.6.2 BioCryst Pharmaceuticals Business Overview
        11.6.3 BioCryst Pharmaceuticals Communicable Diseases Therapeutics Introduction
        11.6.4 BioCryst Pharmaceuticals Revenue in Communicable Diseases Therapeutics Business (2017-2022)
        11.6.5 BioCryst Pharmaceuticals Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck Communicable Diseases Therapeutics Introduction
        11.7.4 Merck Revenue in Communicable Diseases Therapeutics Business (2017-2022)
        11.7.5 Merck Recent Development
    11.8 Boehringer Ingelheim
        11.8.1 Boehringer Ingelheim Company Detail
        11.8.2 Boehringer Ingelheim Business Overview
        11.8.3 Boehringer Ingelheim Communicable Diseases Therapeutics Introduction
        11.8.4 Boehringer Ingelheim Revenue in Communicable Diseases Therapeutics Business (2017-2022)
        11.8.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Communicable Diseases Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of HIV
    Table 3. Key Players of Influenza
    Table 4. Key Players of TB
    Table 5. Key Players of Malaria
    Table 6. Key Players of Hepatitis
    Table 7. Key Players of HPV
    Table 8. Global Communicable Diseases Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Communicable Diseases Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Communicable Diseases Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Communicable Diseases Therapeutics Market Share by Region (2017-2022)
    Table 12. Global Communicable Diseases Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Communicable Diseases Therapeutics Market Share by Region (2023-2028)
    Table 14. Communicable Diseases Therapeutics Market Trends
    Table 15. Communicable Diseases Therapeutics Market Drivers
    Table 16. Communicable Diseases Therapeutics Market Challenges
    Table 17. Communicable Diseases Therapeutics Market Restraints
    Table 18. Global Communicable Diseases Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Communicable Diseases Therapeutics Market Share by Players (2017-2022)
    Table 20. Global Top Communicable Diseases Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Communicable Diseases Therapeutics as of 2021)
    Table 21. Ranking of Global Top Communicable Diseases Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Communicable Diseases Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Communicable Diseases Therapeutics Product Solution and Service
    Table 25. Date of Enter into Communicable Diseases Therapeutics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Communicable Diseases Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Communicable Diseases Therapeutics Revenue Market Share by Type (2017-2022)
    Table 29. Global Communicable Diseases Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Communicable Diseases Therapeutics Revenue Market Share by Type (2023-2028)
    Table 31. Global Communicable Diseases Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Communicable Diseases Therapeutics Revenue Market Share by Application (2017-2022)
    Table 33. Global Communicable Diseases Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Communicable Diseases Therapeutics Revenue Market Share by Application (2023-2028)
    Table 35. North America Communicable Diseases Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Communicable Diseases Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Communicable Diseases Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Communicable Diseases Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Communicable Diseases Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Communicable Diseases Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Communicable Diseases Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Communicable Diseases Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Communicable Diseases Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Communicable Diseases Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Novartis Company Detail
    Table 46. Novartis Business Overview
    Table 47. Novartis Communicable Diseases Therapeutics Product
    Table 48. Novartis Revenue in Communicable Diseases Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Novartis Recent Development
    Table 50. Gilead Company Detail
    Table 51. Gilead Business Overview
    Table 52. Gilead Communicable Diseases Therapeutics Product
    Table 53. Gilead Revenue in Communicable Diseases Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Gilead Recent Development
    Table 55. GSK Company Detail
    Table 56. GSK Business Overview
    Table 57. GSK Communicable Diseases Therapeutics Product
    Table 58. GSK Revenue in Communicable Diseases Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. GSK Recent Development
    Table 60. Janssen Pharmaceutical Company Detail
    Table 61. Janssen Pharmaceutical Business Overview
    Table 62. Janssen Pharmaceutical Communicable Diseases Therapeutics Product
    Table 63. Janssen Pharmaceutical Revenue in Communicable Diseases Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. Janssen Pharmaceutical Recent Development
    Table 65. Roche Company Detail
    Table 66. Roche Business Overview
    Table 67. Roche Communicable Diseases Therapeutics Product
    Table 68. Roche Revenue in Communicable Diseases Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. Roche Recent Development
    Table 70. BioCryst Pharmaceuticals Company Detail
    Table 71. BioCryst Pharmaceuticals Business Overview
    Table 72. BioCryst Pharmaceuticals Communicable Diseases Therapeutics Product
    Table 73. BioCryst Pharmaceuticals Revenue in Communicable Diseases Therapeutics Business (2017-2022) & (US$ Million)
    Table 74. BioCryst Pharmaceuticals Recent Development
    Table 75. Merck Company Detail
    Table 76. Merck Business Overview
    Table 77. Merck Communicable Diseases Therapeutics Product
    Table 78. Merck Revenue in Communicable Diseases Therapeutics Business (2017-2022) & (US$ Million)
    Table 79. Merck Recent Development
    Table 80. Boehringer Ingelheim Company Detail
    Table 81. Boehringer Ingelheim Business Overview
    Table 82. Boehringer Ingelheim Communicable Diseases Therapeutics Product
    Table 83. Boehringer Ingelheim Revenue in Communicable Diseases Therapeutics Business (2017-2022) & (US$ Million)
    Table 84. Boehringer Ingelheim Recent Development
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Communicable Diseases Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. HIV Features
    Figure 3. Influenza Features
    Figure 4. TB Features
    Figure 5. Malaria Features
    Figure 6. Hepatitis Features
    Figure 7. HPV Features
    Figure 8. Global Communicable Diseases Therapeutics Market Share by Application in 2021 & 2028
    Figure 9. Hospital Case Studies
    Figure 10. Clinic Case Studies
    Figure 11. Other Case Studies
    Figure 12. Communicable Diseases Therapeutics Report Years Considered
    Figure 13. Global Communicable Diseases Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Communicable Diseases Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Communicable Diseases Therapeutics Market Share by Region: 2021 VS 2028
    Figure 16. Global Communicable Diseases Therapeutics Market Share by Players in 2021
    Figure 17. Global Top Communicable Diseases Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Communicable Diseases Therapeutics as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Communicable Diseases Therapeutics Revenue in 2021
    Figure 19. North America Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Communicable Diseases Therapeutics Market Share by Country (2017-2028)
    Figure 21. United States Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Communicable Diseases Therapeutics Market Share by Country (2017-2028)
    Figure 25. Germany Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Communicable Diseases Therapeutics Market Share by Region (2017-2028)
    Figure 33. China Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Communicable Diseases Therapeutics Market Share by Country (2017-2028)
    Figure 41. Mexico Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Communicable Diseases Therapeutics Market Share by Country (2017-2028)
    Figure 45. Turkey Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Communicable Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Novartis Revenue Growth Rate in Communicable Diseases Therapeutics Business (2017-2022)
    Figure 48. Gilead Revenue Growth Rate in Communicable Diseases Therapeutics Business (2017-2022)
    Figure 49. GSK Revenue Growth Rate in Communicable Diseases Therapeutics Business (2017-2022)
    Figure 50. Janssen Pharmaceutical Revenue Growth Rate in Communicable Diseases Therapeutics Business (2017-2022)
    Figure 51. Roche Revenue Growth Rate in Communicable Diseases Therapeutics Business (2017-2022)
    Figure 52. BioCryst Pharmaceuticals Revenue Growth Rate in Communicable Diseases Therapeutics Business (2017-2022)
    Figure 53. Merck Revenue Growth Rate in Communicable Diseases Therapeutics Business (2017-2022)
    Figure 54. Boehringer Ingelheim Revenue Growth Rate in Communicable Diseases Therapeutics Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Gilead
GSK
Janssen Pharmaceutical
Roche
BioCryst Pharmaceuticals
Merck
Boehringer Ingelheim
Frequently Asked Questions
Communicable Diseases Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Communicable Diseases Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Communicable Diseases Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports